Clinical outcomes stratified by baseline functional class after initial combination therapy for pulmonary arterial hypertension

BACKGROUND: Initial combination therapy with ambrisentan and tadalafil reduced the risk of clinical failure events for treatment-naïve participants with pulmonary arterial hypertension (PAH) as compared to monotherapy. Previous studies in PAH have demonstrated greater treatment benefits in more symp...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Respir Res
Autores principales: White, R. James, Vonk-Noordegraaf, Anton, Rosenkranz, Stephan, Oudiz, Ronald J., McLaughlin, Vallerie V., Hoeper, Marius M., Grünig, Ekkehard, Ghofrani, Hossein-Ardeschir, Chakinala, Murali M., Barberà, Joan A., Blair, Christiana, Langley, Jonathan, Frost, Adaani E.
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6739949/
https://ncbi.nlm.nih.gov/pubmed/31511080
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-019-1180-1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares